Yokogawa Hideaki, Hayashi Takahiko, Kobayashi Akira, Mori Natsuko, Yamazaki Kenichiro, Ohta Hirohito, Takeda Masato, Igarashi Ami, Yamagami Satoru
Department of Ophthalmology, Kanazawa University Hospital, 13-1 Takara-machi, Kanazawa-shi, Ishikawa-ken, 920-8641, Japan.
Department of Ophthalmology, Department of Visual Sciences, Nihon University School of Medicine, Itabashi, Tokyo, Japan.
Jpn J Ophthalmol. 2025 May 26. doi: 10.1007/s10384-025-01215-1.
To assess the outcomes of Descemet membrane endothelial keratoplasty (DMEK) staged after implantation of presbyopia-correcting intraocular lenses (IOLs) in patients with coexisting Fuchs endothelial corneal dystrophy (FECD) and cataract.
Retrospective, interventional case series METHODS: We enrolled six eyes of three patients with coexisting FECD and cataract (3 women, age 67.8 ± 6.5 years) treated with presbyopia-correcting IOL implantation, followed by DMEK. The modified Krachmer grade, visual outcomes, and incidence of intra- and postoperative complications were analyzed.
Modified Krachmer FECD grades 4, 5, and 6 were observed in one, two, and three eyes, respectively. The mean best-corrected visual acuity (BCVA) was dissatisfactory with the primary presbyopia-correcting IOL (decimal 0.45), it improved significantly (decimal 1.0, P = 0.027) after DMEK and all eyes acquired satisfactory uncorrected distance and near (30 cm) vision (mean, decimal, distance 0.85 and near 0.56). The manifest spherical equivalent after DMEK was within the acceptable range (-0.375 D to 0.0 D). Rebubbling was required in four eyes, but no instances of other postoperative complications or primary graft failure were encountered.
DMEK staged after implantation of presbyopia-correcting IOLs is a viable option for patients with coexisting FECD and cataract.
评估在患有富克斯内皮角膜营养不良(FECD)和白内障的患者中,植入矫正老花眼的人工晶状体(IOL)后分期进行Descemet膜内皮角膜移植术(DMEK)的效果。
回顾性、干预性病例系列
我们纳入了3例同时患有FECD和白内障的患者的6只眼(3名女性,年龄67.8±6.5岁),这些患者接受了矫正老花眼的IOL植入术,随后进行了DMEK。分析了改良的Krachmer分级、视力结果以及术中及术后并发症的发生率。
分别在1只眼、2只眼和3只眼中观察到改良的Krachmer FECD分级为4级、5级和6级。初次矫正老花眼的IOL植入后,平均最佳矫正视力(BCVA)不理想(小数视力0.45),DMEK术后显著改善(小数视力1.0,P = 0.027),所有眼睛均获得了满意的未矫正远视力和近视力(30 cm)(平均小数视力,远视力0.85,近视力0.56)。DMEK术后的明显球镜等效度数在可接受范围内(-0.375 D至0.0 D)。4只眼需要再次注气,但未遇到其他术后并发症或原发性移植物失败的情况。
对于同时患有FECD和白内障的患者,在植入矫正老花眼的IOL后分期进行DMEK是一种可行的选择。